Introduction The mechanism underlying the development of excessive daytime sleepiness (EDS) in obstructive sleep apnea (OSA) remains unclear. Thus, we characterised the association between sleep architecture and EDS in individuals with and without OSA. Methods 1876 suspected OSA patients reporting daytime sleepiness underwent in-lab polysomnography and next-day multiple sleep latency test (MSLT). We investigated sleep architecture characteristics in OSA (apnea-hypopnea index [AHI]≥5, n=1508) and non-OSA (AHI<5, n=368) patients with and without EDS (MSLT≤10-minutes and MSLT>10-minutes). Sleep architecture was quantified by N1, N2, N3, REM, total sleep time (TST), and wake after sleep onset (WASO). Results OSA patients with EDS had less N1 (median: 10.0 vs 12.0-minutes, p<0.05) and N3 (60.2 vs 71.5-minutes, p<0.05) sleep, less WASO (43.0 vs 51.0-minutes, p<0.05), more N2 (210.5 vs 189.0-minutes, p<0.05) sleep, and higher TST (365.0 vs 351.5-minutes, p<0.05) than non-EDS patients. No difference was observed in the amount of REM (70.0 vs 67.5-minutes, p=0.46) sleep. Non-OSA patients with EDS had less WASO (31.5 vs 40.0-minutes, p<0.05), more N2 (188.5 vs 177.5-minutes, p<0.05) sleep, and higher TST (374.5 vs 359.0-minutes, p<0.05) and the amount of REM sleep (76.5 vs 68.5-minutes, p<0.05) than non-EDS patients. Discussion While EDS was associated with less WASO and greater TST and N2 in both OSA and non-OSA groups, there was also characteristic differences. Non-OSA patients with EDS have greater REM sleep duration, while OSA patients with EDS have less N3 sleep. There is likely a complex bi-directional relationship between sleep architecture and EDS reflecting acute/chronic sleep disruption and compensatory mechanisms.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.